Gene · 406953
Papers4,478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,478
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SRSF3 shapes the structure of miR-17-92 cluster RNA and promotes selective processing of miR-17 and miR-20a. | EMBO Rep | 2023 | 37306233 | PubTator, text mining | PubMed |
| Air Pollution: Role of Extracellular Vesicles-Derived Non-Coding RNAs in Environmental Stress Response. | Cells | 2023 | 37296619 | PubTator, text mining | PubMed |
| Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway. | Cell Cycle | 2023 | 37287276 | PubTator, text mining | PubMed |
| miR-18a expression correlates with ATM and p53 levels and poor prognosis in lymphomas. | J Cancer | 2023 | 37283790 | PubTator, text mining | PubMed |
| MicroRNA-19a-3p Decreases with Age in Mice and Humans and Inhibits Osteoblast Senescence. | JBMR Plus | 2023 | 37283656 | PubTator, text mining | PubMed |
| Sjögren's syndrome: novel insights from proteomics and miRNA expression analysis. | Front Immunol | 2023 | 37275849 | PubTator, text mining | PubMed |
| Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection. | Curr Res Immunol | 2023 | 37273890 | PubTator, text mining | PubMed |
| The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure. | Front Cardiovasc Med | 2023 | 37273885 | PubTator, text mining | PubMed |
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. | ESMO Open | 2023 | 37263082 | PubTator, text mining | PubMed |
| Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer. | Sci Rep | 2023 | 37258567 | PubTator, text mining | PubMed |
| Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. | MedComm (2020) | 2023 | 37256211 | PubTator, text mining | PubMed |
| Relationship between Monoclonal Gammopathy of undetermined significance and multiple myeloma via online database analysis. | Pak J Med Sci | 2023 | 37250588 | PubTator, text mining | PubMed |
| miRNAs contributing to the repair of tendon injury. | Cell Tissue Res | 2023 | 37249708 | PubTator, text mining | PubMed |
| LncRNA CASC2 Inhibits Progression of Glioblastoma by Regulating the Expression of AKT in T98G Cell Line, Treated by TMZ and Thiosemicarbazone Complex. | Asian Pac J Cancer Prev | 2023 | 37247274 | PubTator, text mining | PubMed |
| Crosstalk between long noncoding RNA and microRNA in Cancer. | Cell Oncol (Dordr) | 2023 | 37245177 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review. | Pharmaceutics | 2023 | 37242569 | PubTator, text mining | PubMed |
| Modulation of Ferroptosis by microRNAs in Human Cancer. | J Pers Med | 2023 | 37240889 | PubTator, text mining | PubMed |
| Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients. | Int J Mol Sci | 2023 | 37240431 | PubTator, text mining | PubMed |
| Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition. | Int J Mol Sci | 2023 | 37240281 | PubTator, text mining | PubMed |
| Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. | Biology (Basel) | 2023 | 37237523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406953/papers?page=15